Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Genmab A/S (GNMSF) had Normalized Pre-Tax Income of $295.00M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$1.16B |
|
$303.00M |
|
$84.00M |
|
$1.07B |
|
$780.00M |
|
$375.00M |
|
$-80.00M |
|
$295.00M |
|
|
Normalized Pre-Tax Income |
$295.00M |
$303.00M |
|
$303.00M |
|
$303.00M |
|
$303.00M |
|
$375.00M |
|
$401.00M |
|
61.34M |
|
61.71M |
|
$4.94 |
|
$4.91 |
|
| Balance Sheet Financials | |
$2.80B |
|
$137.00M |
|
$9.71B |
|
$12.52B |
|
$1.14B |
|
$4.84B |
|
$5.42B |
|
$6.56B |
|
$5.96B |
|
$-3.27B |
|
$5.96B |
|
62.35M |
|
| Cash Flow Statement Financials | |
$54.00M |
|
$-7.00M |
|
$-252.00M |
|
$1.72B |
|
$1.50B |
|
$-212.00M |
|
$86.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.46 |
|
-- |
|
-- |
|
0.45 |
|
0.86 |
|
92.73% |
|
32.47% |
|
32.47% |
|
-- |
|
25.54% |
|
26.23% |
|
$47.00M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
4.67 |
|
0.90 |
|
99.74 |
|
5.09% |
|
-9.27% |
|
2.42% |
|
2.81% |
|
$95.54 |
|
$0.76 |
|
$0.88 |
|